News
Meet the team: a chat with Sebastiaan Heidt (Leiden University Medical Center)
In this interview, Dr. Heidt explains the contribution of Leiden University Medical Center to the immunological part of ULISES.
Cancer Curing and Vaccination
Watch the videoNanotechnologies to help in new cancer treatment strategy
ULISES is set to develop an immunologic-based treatment strategy where cancer cells are reprogrammed to become “visible” to the patients’ immune system.
According to the statistics from the World Health Organization, cancer is the second leading cause of death globally, counting for approximately 9.6 million deaths in 2018. This figure is expected to increase by 60% by 2040 due to the ageing and increase of the world’s population.
While cancer treatments are currently based on surgical resection of the tumour (if possible), chemotherapy, radiotherapy, target-driven therapies and immunotherapy, ULISES aims to set out an all-new therapeutic strategy based on nanotechnologies.
Latest updates
News
Meet the team: a chat with Alfredo Minguela Puras (Biomedical Research Institute of Murcia)
In this interview, dr. Alfredo Minguela Puras, from the Biomedical Research Institute of Murcia, explains how his team is validating the ULISES therapy developed by the consortium through in vitro and in vivo (in humanized mice) assays.
News
“We, cancer patients, fighting against stigma and discrimination”
Laura has beaten cancer but never been the same since. After being refused loans, mortgages, and adoption, she understood being one of many cancer survivors facing discrimination. And made of it a political commitment to their rights. Because “we are not half people, and still have all our dignity intact. And this is what I’m fighting for”